5PSQ-029 Evaluation of the efficacy and safety of erenumab in the prophylaxis of chronic and episodic migraine

AM Martínez Soto; M García Coronel; C Pastor Mondéjar; JM Marco Puig; P Ortiz Fernandez; P Fernández-Villacañas Fernández; C Caballero Requejo; L Rentero Redondo; C Iniesta Navalón; I Salar Valverde; E Urbieta Sanz

doi:10.1136/ejhpharm-2022-eahp.266

Article info

PDF

Section 5: Patient safety and quality assurance

5PSQ-029 Evaluation of the efficacy and safety of erenumab in the prophylaxis of chronic and episodic migraine

Free

Authors

AM Martínez Soto Hospital General Universitario Reina Sofía, Pharmacy, Murcia, Spain PubMed articles Google scholar articles
M García Coronel Hospital General Universitario Reina Sofía, Pharmacy, Murcia, Spain PubMed articles Google scholar articles
C Pastor Mondéjar Hospital General Universitario Reina Sofía, Pharmacy, Murcia, Spain PubMed articles Google scholar articles
JM Marco Puig Hospital General Universitario Reina Sofía, Pharmacy, Murcia, Spain PubMed articles Google scholar articles
P Ortiz Fernandez Hospital General Universitario Reina Sofía, Pharmacy, Murcia, Spain PubMed articles Google scholar articles
P Fernández-Villacañas Fernández Hospital General Universitario Reina Sofía, Pharmacy, Murcia, Spain PubMed articles Google scholar articles
C Caballero Requejo Hospital General Universitario Reina Sofía, Pharmacy, Murcia, Spain PubMed articles Google scholar articles
L Rentero Redondo Hospital General Universitario Reina Sofía, Pharmacy, Murcia, Spain PubMed articles Google scholar articles
C Iniesta Navalón Hospital General Universitario Reina Sofía, Pharmacy, Murcia, Spain PubMed articles Google scholar articles
I Salar Valverde Hospital General Universitario Reina Sofía, Pharmacy, Murcia, Spain PubMed articles Google scholar articles
E Urbieta Sanz Hospital General Universitario Reina Sofía, Pharmacy, Murcia, Spain PubMed articles Google scholar articles

Citation

Martínez Soto A, García Coronel M, Pastor Mondéjar C, et al

5PSQ-029 Evaluation of the efficacy and safety of erenumab in the prophylaxis of chronic and episodic migraine

European Journal of Hospital Pharmacy 2022;29:A127.

Publication history

First published March 23, 2022.

Online issue publication

April 22, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password